Avail Health adds former Aetna Medicare CMO Ali Khan to board

Avail Health named former Aetna Medicare Chief Medical Officer Ali Khan to its board as the company readies an equity financing round and expands its value-based care footprint. The appointment comes as Avail aims to grow from about 5,000 lives served to 15,000 in 2027 and enter new states.

Why it matters: - Avail Health is trying to scale a technology-enabled care model across more states and more patients. - Adding a Medicare and value-based care veteran gives the company board-level experience in payer strategy, clinical innovation and population health. - The move comes as Avail prepares its first priced equity financing round.

What happened: - Avail Health appointed Ali Khan, M.D., M.P.P., FACP, former Chief Medical Officer for Medicare at Aetna, to its Board of Directors. - Khan joins a company founded in 2024 that serves about 5,000 lives across five states: California, Maryland, West Virginia, Ohio and Indiana. - Avail said Khan will help guide growth partnerships, clinical innovation and broader industry relationships.

The details: - Khan previously served as Chief Medical Officer for Value-Based Care Strategy at Oak Street Health. - He also held senior clinical leadership roles at CareMore Health and Iora Health. - Avail said Khan helped build and scale care models for medically complex and high-risk populations. - Avail has expanded without institutional venture capital funding, relying on what it described as a capital-efficient growth model. - The company plans to reach about 15,000 lives in 2027. - Avail expects to enter Pennsylvania, Virginia, Kentucky and additional markets. - The company’s Nexus platform combines clinical care delivery, population health analytics and operational management. - Nexus is designed for health plans, accountable care organizations and other risk-bearing entities. - The platform uses clinical and claims data to identify high-risk populations, coordinate care teams, track utilization and quality, and produce population health reporting. - Avail says the platform supports medical management, behavioral health, care transitions, chronic care management, risk adjustment, model of care compliance and quality improvement. - Dr. Khan’s relationship with Avail leadership predates the board appointment through prior work with CEO Joseph Harrison, VP of Care Delivery Katie Korte and VP of Operations Jordan Coleman.

Between the lines: - The board addition appears aimed at strengthening credibility with payers and other risk-bearing organizations as Avail tries to move from early traction to national scale. - Khan’s background bridges payer leadership and provider-side value-based care execution, which fits Avail’s business model. - The financing round suggests Avail is moving from mostly self-funded growth to a more formal scale-up phase.

What's next: - Avail will use the new board relationship to support platform expansion, clinical operations and national partnerships. - The company plans further geographic growth as it works toward its 2027 patient target. - Khan is expected to support strategic relationships across the healthcare industry.

The bottom line: - Avail is pairing a seasoned Medicare executive with a growth push that depends on proving its care model can scale across markets and payer relationships.